Please login to the form below
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Environment: where does the pharmaceutical industry stand?
- Novartis reports death of two patients treated with Zolgensma
- ONS data reveals significant decrease in COVID-19 antibodies
- bluebird bio reveals plans to launch two gene therapies
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- Novartis’ Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
- There's No Going Back: How COVID-19 will Change Pharma Forever
- Shaping the dermatology landscape: Independent expert analysis of the pipeline in 5 disease areas
- Transforming clinical trials to accelerate drug development
- How the WHO hepatitis strategy measures up in the field
- Merck and Orna agree on deal worth $3.5bn for RNA technology
- bluebird bio’s beta-thalassaemia gene therapy receives FDA approval
- ONS data reveals significant decrease in COVID-19 antibodies
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS’s oral AML therapy Onureg receives EU approval
- FDA approves Incyte’s Opzelura for vitiligo
- Promoting off-label use: where to draw the line?
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Shaping the dermatology landscape: Independent expert analysis of the pipeline in 5 disease areas
- Leading dermatologists discuss the innovations shaping 5 chronic skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa—and share the challenges and opportunities for biopharmaceutical companies developing innovative treatments....
- Transforming clinical trials to accelerate drug development
- ...
- How the WHO hepatitis strategy measures up in the field
- With hepatitis cases on the rise, Dr Anthony Martinez, member of the International Hepatitis Education Program (IHEP), shares his perspective on the World Health Organization’s new strategy for hepatitis elimination...
